Kajsa Kvist

2.2k total citations · 2 hit papers
33 papers, 1.5k citations indexed

About

Kajsa Kvist is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Psychiatry and Mental health. According to data from OpenAlex, Kajsa Kvist has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 5 papers in Psychiatry and Mental health. Recurrent topics in Kajsa Kvist's work include Diabetes Treatment and Management (16 papers), Diabetes Management and Research (13 papers) and Suicide and Self-Harm Studies (4 papers). Kajsa Kvist is often cited by papers focused on Diabetes Treatment and Management (16 papers), Diabetes Management and Research (13 papers) and Suicide and Self-Harm Studies (4 papers). Kajsa Kvist collaborates with scholars based in Denmark, United States and United Kingdom. Kajsa Kvist's co-authors include Per Kragh Andersen, Lars Vedel Kessing, John B. Buse, Bernard Zinman, Thomas R. Pieber, Steven P. Marso, Richard E. Pratley, Lars Søndergård, Neil R Poulter and Alan C. Moses and has published in prestigious journals such as New England Journal of Medicine, JAMA and Diabetes Care.

In The Last Decade

Kajsa Kvist

33 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

2017 409 citations Steven P. Marso, Darren K. McGuire et al. New England Journal of Medicine profile →
Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers

2022 134 citations Caroline Holm Nørgaard, Sarah Friedrich et al. Alzheimer s & Dementia Translational Research & Clinical Interventions profile →

Peers

Countries citing papers authored by Kajsa Kvist

Since Specialization

Citations

This map shows the geographic impact of Kajsa Kvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kajsa Kvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kajsa Kvist more than expected).

Fields of papers citing papers by Kajsa Kvist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kajsa Kvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kajsa Kvist. The network helps show where Kajsa Kvist may publish in the future.

Co-authorship network of co-authors of Kajsa Kvist

This figure shows the co-authorship network connecting the top 25 collaborators of Kajsa Kvist. A scholar is included among the top collaborators of Kajsa Kvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kajsa Kvist. Kajsa Kvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Beyond the Cox Hazard Ratio: A Targeted Learning Approach to Survival Analysis in a Cardiovascular Outcome Trial Application 2023 ·Statistics in Biopharmaceutical Research ·(unknown), Maya L. Petersen, Helene C. W. Rytgaard, Randi Grøn, Theis Lange, Søren Rasmussen, Richard E. Pratley, Steven P. Marso, Kajsa Kvist, John B. Buse, Mark J. van der Laan	1
2	Increased Derived Time in Range Is Associated with Reduced Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and Microvascular Events in Type 2 Diabetes: A Post Hoc Analysis of DEVOTE 2023 ·Diabetes Technology & Therapeutics ·Richard M. Bergenstal, (unknown), Kajsa Kvist, Anne L. Peters, (unknown), John B. Buse	17
3	Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers breakdown → 2022 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·Caroline Holm Nørgaard, Sarah Friedrich, Charlotte T. Hansen, Thomas Alexander Gerds, Clive Ballard, Daniél Vega Møller, Lotte Bjerre Knudsen, Kajsa Kvist, Bernard Zinman, Ellen Holm, Christian Torp‐Pedersen, Lina Steinrud Mørch	134
4	Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes 2021 ·Diabetes Care ·Anna R. Kahkoska, (unknown), G. Caleb Alexander, Tellen D. Bennett, Christopher G. Chute, Melissa Haendel, Klara R. Klein, Hemalkumar B. Mehta, Joshua D. Miller, Richard A. Moffitt, Til Stürmer‎, Kajsa Kvist, John B. Buse, Timothy Q. Duong	41
5	Development of a hypoglycaemia risk score to identify high‐risk individuals with advanced type 2 diabetes in DEVOTE 2020 ·Diabetes Obesity and Metabolism ·Simon Heller, Ildiko Lingvay, Steven P. Marso, Athena Philis‐Tsimikas, Thomas R. Pieber, Neil R Poulter, Richard E. Pratley, (unknown), Kajsa Kvist, Martin Lange, Alan C. Moses, (unknown), John B. Buse, (unknown)	9
6	Liraglutide and semaglutide: Pooled post hoc analysis to evaluate risk of dementia in patients with type 2 diabetes 2020 ·Alzheimer s & Dementia ·Clive Ballard, Caroline Holm Nørgaard, Sarah Friedrich, Lina Steinrud Mørch, Thomas Alexander Gerds, Daniél Vega Møller, Lotte Bjerre Knudsen, Kajsa Kvist, Bernard Zinman, Ellen Holm, Christian Torp‐Pedersen, Charlotte T. Hansen	18
7	Glycemic Variability Associated with Time Spent in Hypoglycemia in Type 1 Diabetes—Explorative Data in Real-World, Real-Time Continuous Glucose Monitoring 2018 ·Diabetes ·(unknown), (unknown), Christian Djurhuus, Kajsa Kvist	2
8	Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes breakdown → 2017 ·New England Journal of Medicine ·Steven P. Marso, Darren K. McGuire, Bernard Zinman, Neil R Poulter, Scott S. Emerson, Thomas R. Pieber, Richard E. Pratley, (unknown), Martin Lange, Kirstine Brown‐Frandsen, Alan C. Moses, Simon Skibsted, Kajsa Kvist, John B. Buse	409
9	Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2) 2017 ·Diabetologia ·(unknown), Bernard Zinman, Steven P. Marso, Neil R Poulter, Scott S. Emerson, Thomas R. Pieber, Richard E. Pratley, Martin Lange, Kirstine Brown‐Frandsen, Alan C. Moses, Ann Marie Ocampo Francisco, (unknown), Kajsa Kvist, John B. Buse	128
10	Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone 2016 ·Clinical Drug Investigation ·Tina Vilsbøll, Jiten Vora, (unknown), Kajsa Kvist, Lawrence Blonde	8
11	IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy 2015 ·Diabetes Therapy ·Nick Freemantle, Muhammad Mamdani, Tina Vilsbøll, (unknown), Kajsa Kvist, Stephen C. Bain	23
12	Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting 2014 ·Current Medical Research and Opinion ·(unknown), Sara Larsson Lönn, Kajsa Kvist	2
13	Similarities and differences in borderline and organic personality disorder 2013 ·Cognitive Neuropsychiatry ·Birgit Bork Mathiesen, Erik Simonsen, (unknown), Kajsa Kvist	4
14	Event dependent sampling of recurrent events 2010 ·Lifetime Data Analysis ·Kajsa Kvist, Per Kragh Andersen, Jules Angst, Lars Vedel Kessing	11
15	Repeated events and total time on test 2008 ·Statistics in Medicine ·Kajsa Kvist, Per Kragh Andersen, Jules Angst, Lars Vedel Kessing	4
16	Non‐parametric estimation and model checking procedures for marginal gap time distributions for recurrent events 2007 ·Statistics in Medicine ·Kajsa Kvist, Mette Gerster, Per Kragh Andersen, Lars Vedel Kessing	3
17	Treatment with antiparkinson and antidepressant drugs: A register‐based, pharmaco‐epidemiological study 2007 ·Movement Disorders ·Mette Brandt‐Christensen, Kajsa Kvist, Flemming Mørkeberg Nilsson, Per Kragh Andersen, Lars Vedel Kessing	11
18	Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study 2007 ·Bipolar Disorders ·Lars Vedel Kessing, Lars Søndergård, Kajsa Kvist, Per Kragh Andersen	39
19	Do antidepressants precipitate youth suicide? 2006 ·European Child & Adolescent Psychiatry ·Lars Søndergård, Kajsa Kvist, Per Kragh Andersen, Lars Vedel Kessing	37
20	Structured home visits to older people. Are they only of benefit for women? A randomised controlled trial 2004 ·Scandinavian Journal of Primary Health Care ·Mikkel Vass, Kirsten Avlund, Kajsa Kvist, Carsten Hendriksen, Christian Kronborg, Niels Keiding	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact